Background
==========

Gastric outlet obstruction (GOO) presents with nausea and vomiting and usually develops over weeks to months \[[@B1]\]. It may be complete or incomplete with intermittent symptoms. In the past, peptic ulcer disease was considered as the most common cause of GOO; more recently, gastric malignancy has become a more frequent entity \[[@B2]\]. The rare causes are bezoars, foreign bodies, Bouveret\'s syndrome, hypertrophic pyloric stenosis, and large polyps of the antrum or pyloric channel \[[@B3]-[@B6]\].

Gastric polyps are incidentally detected in 2--3% of upper gastrointestinal endoscopic examinations \[[@B7]\]. The most common type of gastric polyps is hyperplastic polyps, which account for nearly 85--90% of cases \[[@B7],[@B8]\]. They are usually seen in adults, over 60 years of age \[[@B8]\]. These polyps are often pinkish, round-shaped, solitary, and small (\<2 cm) and classified as either sessile or pedunculated. While small polyps tend to be sessile, the larger ones may have a short stalk \[[@B8]\]. Most of them are localized at the junction of fundic and pyloric mucosa. Multiple hyperplastic polyps are found in 20% of the patients \[[@B9]\].

Until recently it was believed that the hyperplastic polyps do not undergo malignant transformation, but carcinomas associated with hyperplastic polyps were reported in the literature over the past few years \[[@B10],[@B11]\]. Interestingly, an association between hyperplastic polyps and *Helicobacter pylori*(*H. pylori*) gastritis has been proposed in some recent studies \[[@B12],[@B13]\].

In this report, we present a patient who had a gastric hyperplastic polyp causing GOO and a review of the pertinent literature.

Case presentation
=================

A 62-year-old woman (A.K., \#5202) applied to our institute with complaints of nausea and vomiting. She described four episodes of similar type, each lasting 2 to 3 days, in the last 4 months. Her medical background and family history were unremarkable and physical examination was normal. The standard laboratory results (whole blood count, glucose, blood urea nitrogen, creatinine, electrolytes, prothrombin time, and partial thromboplastin time) were also within normal limits. Upper gastrointestinal endoscopy revealed a 30 mm prepyloric sessile polyp covered with normal mucosa and which partially obstructed the entrance of the pyloric channel Figure [1A](#F1){ref-type="fig"}. The patient\'s gastric outlet obstruction was ascribed to this pathology and a polypectomy was carried out in the same session. The polyp was slightly elevated by submucosal injection of diluted adrenaline solution (0.0125 mg/mL in saline) targeted at 4 points around the base Figure [1B](#F1){ref-type="fig"}. The polyp was removed with a snare and diathermy was used at a level of 40 watts Figure [1C](#F1){ref-type="fig"}. Two biopsies were taken from both the antrum and the corpus for rapid urease test. Four samples from each sites of the greater curvature of the antrum and the corpus were also taken to assess any atrophy, intestinal metaplasia or gastritis. Rapid urease test for *H. pylori*yielded a negative result. Histopathologic examination of the polypectomy specimen showed a hyperplastic polyp without any malignant features Figure [2](#F2){ref-type="fig"}. Biopsies of the antrum and the corpus revealed gastritis with no evidence of atrophic changes or intestinal metaplasia. *H. pylori*was not observed by either Hematoxylin and Eosin or modified Giemsa stains. Follow-up endoscopy after a 12-week course of proton pomp inhibitor (PPI) therapy showed a complete healing of the polypectomy site with no remnant tissue related to the polyp Figure [3](#F3){ref-type="fig"}. The patient has been symptom-free during 8 months of follow-up.

![**A)** A prepyloric polyp causing obstruction at the pyloric channel. **B)**Injection of diluted adrenaline solution to the base of the polyp. **C)** Removal of the polyp with a snare.](1471-230X-3-16-1){#F1}

![Hyperplastic surface epithelium and cystically dilated glands with inflammatory infiltration and smooth muscle cells in lamina propria, X40, H+E.](1471-230X-3-16-2){#F2}

![A complete healing at the polypectomy site was observed on the follow-up endoscopy after a 12-week course of PPI therapy.](1471-230X-3-16-3){#F3}

Conclusions
===========

Most hyperplastic polyps are usually small (\< 2 cm); however, larger polyps may seldom be encountered on endoscopic examinations. Larger the size of the polyps, higher is the risk of the complications such as obstruction or bleeding. Rarely, hyperplastic polyps may cause dramatic clinical pictures. De La Cruz *et al*. \[[@B14]\] reported a patient with a hyperplastic polyp that caused pancreatitis by prolapsing into the duodenum and compressing the Vater ampulla. Alper *et al*. \[[@B6]\] showed that a large pedunculated antral hyperplastic polyp may cause gastric outlet obstruction and iron deficiency anemia by prolapsing into the duodenum through the pyloric channel. More frequent use of gastroscopic examinations resulted in an increase of incidental diagnosis of hyperplastic polyps. Although it has been widely accepted that every symptomatic polyp should be removed either endoscopically or surgically, there is no particular guideline regarding the evaluation and treatment of asymptomatic hyperplastic polyps.

The exact pathogenesis of hyperplastic polyps is still unclear. The current theory is that an exaggerated regenerative response to mucosal damage occurs \[[@B8]\]. They may be found in association with various forms of chronic gastritis, notably with autoimmune or *H. pylori*gastritis \[[@B9]\]. Abraham *et al*. \[[@B9]\] investigated 160 patients with hyperplastic polyps and found that 85% of the cases had an associated inflammatory mucosal pathology, mostly *H. pylori*gastritis. Not only inflammatory changes, but also malignant foci in other parts of the gastric mucosa may be detected in patients with hyperplastic polyps. Accordingly, taking biopsies from the remote gastric mucosa in order to evaluate any inflammatory changes or malignant transformation has been advocated \[[@B15]\].

There is still a debate on whether *H. pylori*promotes the development of hyperplastic polyps. In a series of 21 patients with gastric hyperplastic polyp, *H. pylori*was positive in 76% of the patients \[[@B12]\]. However, in another larger series, 85% (136/160) of the patients had inflammatory mucosal pathology, most commonly active chronic *H. pylori*gastritis (25%) \[[@B9]\]. On the other hand, Varis *et al*. \[[@B16]\] investigated the presence of *H. pylori*in patients with different types of gastric polyps and reported the prevalence of *H. pylori*infection significantly lower in patients with hyperplastic polyps (45%) and foveolar hyperplasia (48%) than in the group with inflammatory polyps (81%). As an interesting observation, Ohkusa *et al*. \[[@B13]\] showed that hyperplastic polyps disappeared after eradication of *H. pylori*in most patients with *H. pylori*associated gastritis. Similarly, Ljubicic *et al*. \[[@B12]\] reported a 40% complete regression rate of hyperplastic polyps in patients who had associated *H. pylori*gastritis after an average follow-up of 14 months. In both trials, endoscopic polypectomy has been recommended as the second-line approach in the management of hyperplastic polyps associated with *H. pylori*gastritis, when eradication therapy fails to achieve complete polyp regression \[[@B12],[@B13]\]. However, this approach has not been unanimously accepted. The policy in our institute is to remove single polyps of any diameter regardless whether the patient has or not associated *H. pylori*gastritis. When there are multiple polyps, the strategy is determined by the results of *H. pylori*urease test: if negative, all the polyps are removed; but if positive, polyps larger than 15 mm in diameter are removed whereas sampling polypectomy and eradication therapy are offered to the smaller ones. Then, these patients are submitted to endoscopic surveillance.

Contrary to the previous belief, recent studies have revealed that hyperplastic polyps may include dysplastic foci and even undergo malignant degeneration \[[@B10],[@B11]\]. Hizawa *et al*. \[[@B11]\] reported the incidence of malignancy in the hyperplastic polyps as 2%.

In summary, symptomatic gastric polyps presenting as the case above should be removed preferentially when they are detected at the initial diagnostic endoscopy. Polypectomy not only provides tissue to determine the exact histopathologic type of the polyp, but also achieves radical treatment. The same strategy can be used for asymptomatic polyps, where biopsy samples may yield inconclusive results by sampling error. Evidence now is in favour of polypectomy even though the histopathologic examination shows that these are hyperplastic polyps. Additionally, in patients with gastric polyps, other parts of the gastric mucosa should also be histologically evaluated by multiple biopsies for detection of any accompanying inflammatory changes or malignancy. After polypectomy, endoscopic follow-up can be recommended, because of the possibility of recurrence at the polypectomy site and of development of malignancy in the remote gastric mucosa.
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